Blood News and Research

RSS

Childhood dietary patterns influence arterial stiffness in adolescence

Diets high in calories, fat and sugar in childhood can cause damage to blood vessel function, known to heighten the risk of early heart attacks and strokes, as early as adolescence according to research funded by the British Heart Foundation (BHF).

10 Jan 2024

New algorithm proves to be a powerful tool for detection and identification of novel bacterial organisms

Researchers developed the NOVA algorithm to systematically analyze bacterial isolates unidentified using traditional methods such as matrix-assisted laser desorption ionization-time of flight mass spectrometry and partial 16S rRNA gene sequencing using whole genome sequencing.

10 Jan 2024

Study reveals mangos attenuates potential against colon cancer

The chemo-preventive potential of Mangiferin (MF) (mango).

10 Jan 2024

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

J.P. Morgan Healthcare Conference – (January 8th, 2024) Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science.

From Thermo Fisher Scientific Inc. 10 Jan 2024

Nicotine beliefs elicit dose-response reactions in human brains

Researchers investigate whether nicotine-related beliefs may influence brain processes in a dose-dependent manner similar to pharmaceutical effects.

10 Jan 2024

Carvedilol improves heart health marker in childhood cancer survivors

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children's Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure.

9 Jan 2024

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

"TimeMachine," an algorithm developed by U.S. researchers, accurately predicts circadian phase from a single blood sample using gene expression, offering a novel, efficient approach to understanding circadian rhythms and their impact on health.

9 Jan 2024

Injectable hydrogel paves the way for painless defibrillation and arrhythmia prevention

A breakthrough study led by Dr. Mehdi Razavi at The Texas Heart Institute (THI), in collaboration with a biomedical engineering team of The University of Texas at Austin (UT Austin) Cockrell School of Engineering led by Dr. Elizabeth Cosgriff-Hernandez, sets the foundation of a ground-breaking treatment regimen for treating ventricular arrhythmia.

9 Jan 2024

AI model predicts aging and disease risk using facial and retinal images

Researchers developed an AI-based model using facial, tongue, and retinal images to estimate biological age, offering a novel approach to predict age-related chronic diseases.

9 Jan 2024

Using machine learning to predict disease progression in multiple sclerosis

A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals.

9 Jan 2024

Smartphone app offers relief for debilitating tinnitus

An international research team has shown that the debilitating impact of tinnitus can be effectively reduced in just weeks by a training course and sound therapy delivered via a smartphone app.

9 Jan 2024

American Heart Association Merit Award fuels three research avenues to tackle heart disease

A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods could help treat heart disease, a genetics expert from Pennsylvania exploring the molecular mechanisms of lipid metabolism and cardiovascular diseases and a California-based professor of cardiovascular medicine studying how vaping impacts the development of abdominal aortic aneurysms are the most recent American Heart Association Merit Award recipients.

9 Jan 2024

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Children and adults with rare, deadly genetic diseases have fresh hope for curative therapies, thanks to a new collaboration between the Innovative Genomics Institute (IGI) and Danaher Corporation, a global life sciences and diagnostics innovator.

9 Jan 2024

Dutch scientists uncover five different biological variants of Alzheimer's disease

Dutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatment.

9 Jan 2024

Hidden identity of blood cancer revealed

Leukemia is a common term used to refer to a form of blood cancer. However, there are different types of leukemia depending on the cell type involved.

9 Jan 2024

Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

9 Jan 2024

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S..

From QIAGEN Manchester Limited 9 Jan 2024

Marking a vital milestone for Vertex and Charles River

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

From Charles River 9 Jan 2024

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives.

From Cellular Origins 9 Jan 2024

Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication

Researchers investigated the genetic underpinnings of Gestational Diabetes Mellitus (GDM) and its relationship with Type 2 Diabetes (T2D) through a genome-wide association study ((GWAS), identifying distinct and shared genetic factors.

9 Jan 2024

Blood News and Research

Childhood dietary patterns influence arterial stiffness in adolescence

New algorithm proves to be a powerful tool for detection and identification of novel bacterial organisms

Study reveals mangos attenuates potential against colon cancer

New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

Nicotine beliefs elicit dose-response reactions in human brains

Carvedilol improves heart health marker in childhood cancer survivors

"TimeMachine" algorithm revolutionizes circadian rhythm analysis with single blood sample

Injectable hydrogel paves the way for painless defibrillation and arrhythmia prevention

AI model predicts aging and disease risk using facial and retinal images

Using machine learning to predict disease progression in multiple sclerosis

Smartphone app offers relief for debilitating tinnitus

American Heart Association Merit Award fuels three research avenues to tackle heart disease

CRISPR cures on the horizon: Breakthrough center aims to heal rare, deadly genetic diseases

Dutch scientists uncover five different biological variants of Alzheimer's disease

Hidden identity of blood cancer revealed

Children with neuroblastomas may benefit from new drug cocktail

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

Marking a vital milestone for Vertex and Charles River

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News